Skip to main content
. 2022 May 12;9:876561. doi: 10.3389/fmed.2022.876561

Table 2.

Prevalence of TE, AA, and SD according to participants' characteristics (n = 404).

Telogen effluvium (TE) Alopecia areata (AA) Seborrheic dermatitis (SD)
Age
≤ 22 109 (66.1) 32 (19.4) 102 (61.8)
>22 138 (57.7%) 68 (28.5) 131 (54.8)
Sex
Male 94 (53.1) 63 (35.6) 105 (59.3)
Female 153 (67.4) 37 (16.3) 128 (56.4)
Year of study
1st year 5 (41.7) 3 (25.0) 3 (25.0)
2nd year 31 (62.0) 9 (18.0) 33 (66.0)
3rd year 42 (75.0) 16 (28.6) 40 (71.4)
4th year 79 (62.2) 36 (28.3) 71 (55.9)
5th year 90 (56.6) 36 (22.6) 86 (54.1)
Family income
0–20,000 22 (50.0) 7 (15.9) 23 (52.3)
20,000–40,000 81 (58.7) 26 (18.8) 85 (61.6)
>40,000 144 (64.9) 67 (30.2) 125 (56.3)
Residence
Urban 201 (61.7) 77 (23.6) 185 (56.7)
Rural 46 (59.0) 23 (29.5) 48 (61.5)
Relationship status
Married 16 (66.7) 4 (16.7) 15 (62.5)
Unmarried 231 (60.8) 96 (25.3) 218 (57.4)
BMI
Underweight 28 (75.7) 8 (21.6) 20 (54.1)
Normal weight 151 (59.2) 56 (22.0) 142 (55.7)
Overweight 68 (60.7) 36 (32.1) 71 (63.4)
Smoking status
Yes 43 (79.6) 33 (61.1) 40 (74.1)
No 204 (58.3) 67(19.1) 193 (55.1)
COVID-19 related fear
Present 164 (71.3) 80 (34.8) 157 (68.3)
Absent 83 (47.7) 20 (11.5) 76 (43.7)
COVID-19 related impact traumatic stress symptoms
Present 171 (71.3) 82 (34.2) 164 (68.3)
Absent 76 (46.3) 18 (11.0) 69 (42.1)
COVID-19 related student stress
High 110 (76.9) 67 (46.9) 109 (76.2)
Average 98 (53.3) 21 (11.4) 92 (50.0)
Low 39 (50.6) 12 (15.6) 32 (41.6)